|
Hasan Ahmad, M.D., clinical associate professor of medicine, received a $575,823 grant from Novartis Pharmaceuticals for "A Randomized Double-blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants with Established Cardiovascular Disease (VICTORION-2 PREVENT)” and a $50,000 grant from Novartis Pharmaceuticals for "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase IIIb Study Evaluating the Effect of Inclisiran on Atherosclerotic Plaque Progression Assessed by Coronary Computed Tomography Angiography (CCTA) in Participants with a Diagnosis of Non-Obstructive Coronary Artery Disease Without Previous Cardiovascular Events (VICTORION-PLAQUE)."
Chandra Bakshi, D.V.M., Ph.D., professor of pathology, microbiology, and immunology, received a $110,311 grant from Veralox Therapeutics for "Development of New Inhibitors to Treat Inflammatory Damage of COVID-19."
Matthew Bronstein, M.D., clinical assistant professor of surgery, received a $39,697 grant from Regeneron for “Profiling of Plasma Before and After Anticoagulant Therapy in Patients Diagnosed with Venous Thromboembolism (VTE).”
Mitchell Cairo, M.D., professor of pediatrics, cell biology and anatomy, medicine, and of pathology, microbiology, and immunology, received a $250,000 grant from Alex’s Lemonade Stand Foundation for "Circumventing Pediatric Solid Tumor Microenvironment Resistance by Combinatorial CAR NK and Immunomodulating Therapy” and a $195,000 grant from Janssen for "NYMC-598, A Phase II Trial of Targeted Immunotherapy with Daratumumab Following Myeloablative Total Body Irradiation (TBI)-Based Conditioning and Allogeneic Hematopoietic Cell Transplantation in Children, Adolescents and Young Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia and Lymphoma (T ALL/T LLy) (ALLO-T-DART) (NCT04972942).”
Dipak Chandy, M.D., professor of medicine and of neurology, received a $3,601 grant from Veracyte, Inc. for “Nightingale: Clinical Utility of Management of Patients with CT and LDCT Identified Pulmonary Nodules Using the Percepta Nasal Swab ClassifiEr-with Familiarization.”
Allen Dozor, M.D., professor of pediatrics, received a $253,424 grant from the Cystic Fibrosis Foundation for "Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)."
Abdelfattah El Ouaamari, Ph.D., associate professor of cell biology and anatomy and of pharmacology, received a $475,273 grant from the NIH for "Sensory Neuromodulation of Pancreatic Beta Cells."
Nicholas Ferreri, Ph.D., professor of pharmacology, received $105,585 in grants from NIH for "Regulation of NKCC2 Isoforms and Blood Pressure by Tumor Necrosis Factor-alpha."
Mitchell Fraiman, M.D., clinical assistant professor of urology, received a $342,329 grant from Francis Medical, Inc. for "Prospective, Multicenter Single-Arm Study of Vanquish Water Vapor Ablation for Prostate Cancer.”
Simon Hanft, M.D., associate professor of neurosurgery, received a $239,900 grant from Imvax, Inc./Medpace Clinical Research, LLC, for “A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma.”
Kristina Harris-Petersen, Ph.D., associate professor of biochemistry and molecular biology, received a $5,000 grant from Altus Assessments/Acuity Insights for “Do Accommodated and Non-Accommodated US-Medical Student Applicants Perform Comparably Across Admission Metrics?”
Diwakar Jain, M.D., professor of medicine, received a $34,961 grant from Amgen, Inc. for “A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein.”
Sankaran Krishnan, M.D., associate professor of pediatrics, received a $174,674 grant from AstraZeneca Pharmaceuticals for "A Phase 2, Randomised, Double-Blind, Placebo and Active Comparator-Controlled Study to Assess Efficacy and Safety of Multiple Dose Levels of AZD5718 Given Orally Once Daily for Twelve Weeks in Adults with Moderate-to-Severe Uncontrolled Asthma" and a $97,140 grant from Areteia Therapeutics for "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 24 Weeks in Participants with Eosinophilic Asthma (EXHALE-4)."
Delong Liu, M.D., Ph.D., professor of medicine, received a $132,189 grant from IQVIA RDS, Inc. for A Phase 3 Open Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314).”
Romeo Mateo, M.D., assistant professor of surgery, received a $218,928 grant from LeMaitre Vascular, Inc., for “Post-Market Registry in Europe and US for the Use of VascuCel.”
Stephen Mayer, M.D., professor of neurology and of neurosurgery, received a $447,250 grant from Trustees of Columbia University for "Stroke Trials Network of Columbia and Cornell.”
Srihari Naidu, M.D., professor of medicine, received a $398,600 grant from Bristol Myers Squibb Company for "Observational Study Protocol CV027-012 Deliver Insights in Hypertrophic Cardiomyopathy and Observational Outcomes in Real World (DISCOVER-HCM): United States Prospective Registry Study” and a $192,711 grant from Myokardia, Inc., for "Clinical Protocol CV027031-A Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy."
Suguru Ohira, M.D., clinical associate professor of surgery, received a $50,000 grant from TransMedics, Inc., for “Sponsor-Initiated OCS Heart Perfusion (OHP-II) Registry.”
Tana Pradhan, D.O., clinical associate professor of obstetrics and gynecology, received a $19,292 grant from K-Group Beta Inc./GOG Foundation for"A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-C3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma."
Patric K. Stanton, Ph.D., professor of cell biology and anatomy and of neurology, received a $50,294 Innovative Intramural Research Grant from Touro University/Lovelace Biomedical Research Institute for "Photobiomodulation Therapy as a New Noninvasive Treatment to Enhance Brain Repair after Traumatic Brain Injury.”
Libor Velisek, M.D., Ph.D., professor of cell biology and anatomy, pediatrics, and of neurology, received a $12,219 grant from Emerald Gate Trust for "Processing Biofield-Exposed Mouse EEG.”
John Welter, M.D., assistant professor of pediatrics, received a $112,954 grant from Armata Pharmaceuticals, Inc., for “A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 Multi-Phage Therapeutic in Subjects with Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas aeruginosa Infection” and a $43,349 grant from Vertex Pharmaceuticals Inc. for “A Non-Interventional Study Evaluating the Impact of Trikafta Initiation on Children and Caregivers of Children with Cystic Fibrosis Aged 2-5 Years in a Real-World Setting.”
|
